Evolvability describes an organism's capacity for producing descendants that are better adapted to a given environment. Mutations that elevate overall point mutation rates can make bacteria more evolvable under certain circumstances and consequently speed the progression of chronic infections and increase the incidence of antibiotic resistance. Little is currently known about how mutations affecting other cellular processes impact microbial evolvability or about how evolvability typically varies as microorganisms experience random mutations due to genetic drift or adapt by beneficial mutations to higher fitness. The proposed research systematically investigates how different kinds of mutations affect the evolvability of Escherichia coli in laboratory evolution experiments.
The first aim i s to test three strain series differing by predominantly deleterious, beneficial, or random mutations to establish baseline expectations.
The second aim i s to recover genotypes that eventually prevail over competitors of higher fitness because they are more evolvable by chronicling mutation dynamics in evolution experiments using deep sequencing, highthroughput genotyping, and deletion and microsatellite markers.
The third aim i s to construct chromosomal reporters with selectable markers for measuring gene amplification and deletion rates. These reporters will be used to isolate new kinds of genomic instability mutators and to examine whether a similar defect potentiated the evolution of a rare metabolic innovation in a 20-year evolution experiment. Throughout, evolvability will be measured on multiple time scales by comparing the initial divergence of marker trajectories in replicate evolution experiments to population genetic simulations and by performing co-culture competition assays between endpoint isolates and a reference strain. When a strain is found with unusually high or low evolvability, the causal mutation will be identified by genome re-sequencing, and its physiological consequences will be investigated to find out why it affects evolutionary potential.

Public Health Relevance

Understanding how different kinds of mutations alter the ability of microorganisms to evolve could help us keep in check disease progression in chronic infections, the evolution of antibiotic resistance, and the emergence of new pathogens. Knowledge of what mutations promote the evolutionary potential of domesticated microbes could lead to improved strains for biotechnology and biomedical research.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Transition Award (R00)
Project #
Application #
Study Section
Special Emphasis Panel (NSS)
Program Officer
Eckstrand, Irene A
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Austin
Schools of Arts and Sciences
United States
Zip Code
Raeside, Colin; Gaffé, Joël; Deatherage, Daniel E et al. (2014) Large chromosomal rearrangements during a long-term evolution experiment with Escherichia coli. MBio 5:e01377-14
Deatherage, Daniel E; Barrick, Jeffrey E (2014) Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol Biol 1151:165-88
Renda, Brian A; Hammerling, Michael J; Barrick, Jeffrey E (2014) Engineering reduced evolutionary potential for synthetic biology. Mol Biosyst 10:1668-78
Hammerling, Michael J; Ellefson, Jared W; Boutz, Daniel R et al. (2014) Bacteriophages use an expanded genetic code on evolutionary paths to higher fitness. Nat Chem Biol 10:178-80
Quandt, Erik M; Deatherage, Daniel E; Ellington, Andrew D et al. (2014) Recursive genomewide recombination and sequencing reveals a key refinement step in the evolution of a metabolic innovation in Escherichia coli. Proc Natl Acad Sci U S A 111:2217-22
Wielgoss, Sebastien; Barrick, Jeffrey E; Tenaillon, Olivier et al. (2013) Mutation rate dynamics in a bacterial population reflect tension between adaptation and genetic load. Proc Natl Acad Sci U S A 110:222-7
Meyer, Justin R; Dobias, Devin T; Weitz, Joshua S et al. (2012) Repeatability and contingency in the evolution of a key innovation in phage lambda. Science 335:428-32
Wielgoss, Sebastien; Barrick, Jeffrey E; Tenaillon, Olivier et al. (2011) Mutation Rate Inferred From Synonymous Substitutions in a Long-Term Evolution Experiment With Escherichia coli. G3 (Bethesda) 1:183-186
Nahku, Ranno; Peebo, Karl; Valgepea, Kaspar et al. (2011) Stock culture heterogeneity rather than new mutational variation complicates short-term cell physiology studies of Escherichia coli K-12 MG1655 in continuous culture. Microbiology 157:2604-10
Jerome, John P; Bell, Julia A; Plovanich-Jones, Anne E et al. (2011) Standing genetic variation in contingency loci drives the rapid adaptation of Campylobacter jejuni to a novel host. PLoS One 6:e16399

Showing the most recent 10 out of 11 publications